Large-scale tonsilectomy study would quantify UK CJD prevalence

September 30, 2004

ISSUE: 2-8 October 2004 A study in this week's issue of THE LANCET describes how two different types of analysis used in conjunction on samples of tonsil tissue is the 'gold standard' method for confirming clinical variant CJD, and that a large-scale screening programme of tonsil tissue is the only way of identifying the true incidence of vCJD infection.

Variant Creutzfeldt-Jakob disease (vCJD) is thought to be caused by dietary or other exposure to bovine spongiform encephalopathy (BSE) prions; 142 people have died of vCJD, although the prevalence of preclinical or subclinical prion infection in the UK is currently unknown.

Since clinical variant CJD is uniformly associated with tonsillar prion infection, Adam Frosh, John Collinge (MRC Prion Unit, Institute of Neurology, London, UK) and colleagues screened 2000 anonymous surgical tonsillectomy specimens for the presence of the rogue prion protein that causes vCJD. The investigators used two techniques to assess each specimen for the abnormal prion.

Although no positive cases of vCJD were identified, the investigators caution that this negative result cannot provide reassurance that relevant community infection is unlikely because of the fairly small sample size, demographic and age-related factors, and unknown test sensitivity during the prolonged incubation period.

Professor Collinge comments: "Our findings suggest that a national large-scale prospective prevalence study of tonsillectomy specimens is necessary. This study should examine fresh frozen specimens since any positive findings can be confirmed by transmission studies to indicator mice. However, the proportion of tonsillectomies done in patients born before the specified bovine offal ban is falling, thus reducing the opportunity to derive meaningful results".

In an accompanying commentary (p 1196), Markus Glatzel (University Hospital of Zurich, Switzerland) concludes: "Previous vCJD prevalence studies, based solely on the histological detection of prion protein accumulation, have detected one positive out of 8318 tested samples, and three positives out of 12,674 tested samples, respectively, which gives estimated prevalences of 120 per million and 237 per million inhabitants. These projections caused substantial turmoil, not least because the lack of frozen tissue precluded further biochemical analysis and additional assays aimed at showing prion infectivity in samples that tested positive. With a protocol like the one used by Frosh and colleagues these difficulties could have been avoided. Therefore, Frosh's protocol should be viewed as the gold standard for vCJD prevalence studies, for now".
-end-
Contact: (Professor Collinge is currently on holiday and unable to deal with media queries this week).

Dr Markus Glatzel, Institute of Neuropathology and National Reference Centre for Prion Diseases, University Hospital of Zurich, CH-8091 Zürich, Switzerland; T) 41-1-255-2849; markus.glatzel@usz.ch

Lancet

Related Vcjd Articles from Brightsurf:

Blood test for prion disease could make blood supply safer
A blood test accurately diagnosed a total of 32 patients with a rare form of prion disease, two new analyses report, offering a potentially valuable tool for preventing prion contamination of the blood supply.

UTHealth research could lead to blood test to detect Creutzfeldt-Jakob disease
The detection of prions in the blood of patients with variant Creutzfeldt-Jakob disease could lead to a noninvasive diagnosis prior to symptoms and a way to identify prion contamination of the donated blood supply, according to researchers at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).

Gut cells are gatekeepers of infectious brain diseases, study finds
Fresh insights into infectious brain conditions help to explain why some people -- and animals -- are more at risk than others.

Fruit fly model of deadly brain diseases could lead to blood test for vCJD
A new model of fatal brain diseases is being developed in the fruit fly by a team led by Dr.

New assay offers improved detection of deadly prion diseases
Transmissible spongiform encephalopathies (TSEs), or prion diseases, are a family of rare progressive, neurodegenerative illnesses that affect both humans and animals.

Sequestered prion protein takes the good mood away, suggests new hypothesis on depression
The discovery of antidepressant drugs led to the first biochemical hypothesis of depression, known as the monoamine hypothesis.

Brain infection study reveals how disease spreads from gut
Diagnosis of deadly brain conditions could be helped by new research that shows how infectious proteins that cause the disease spread.

New test detects toxic prions in blood
The first cases of mad cow disease in humans occurred in the late 1990s and are thought to be the consequence of eating contaminated beef products.

What bank voles can teach us about prion disease transmission and neurodegeneration
Transmission of prions between species is inefficient, and only a small proportion of exposed recipients become sick within their lifetimes.

Study examines blood test to screen for fatal variant Creutzfeldt-Jakob disease
A blood test accurately screened for infection with the agent responsible for variant Creutzfeldt-Jakob disease, a fatal neurological disease.

Read More: Vcjd News and Vcjd Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.